IP Library Granted Patent US 7,440,786
Granted Patent B2
US 7,440,786 · App. 11/012,428 · Granted Oct 21, 2008

Method and apparatus for presentation of noninvasive glucose concentration information

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,440,786
App. No.
11/012,428
Granted
Oct 21, 2008
Kind
B2
Abstract

The invention relates generally to the extraction and/or presentation of glucose concentrations estimated as a function of time into a format that facilitates conveyance of the underlying information. More particularly, glucose concentration histories are presented in terms of risk of behavior, in a video format, and/or in an audio format. The reduction of data into video format, selected by time period, cluster, or glucose concentration response, into an animated or video presentation allows diagnosis and treatment information to be more readily determined and used. Alternatively, glucose concentrations are output through a voice synthesizer or an earcon. These information presentations are useful for both the medical professional and the end user. The information presentation is preferably used with a noninvasive, implantable, semi-continuous, and/or continuous analyte analyzer, such as a glucose concentration analyzer.

Claims (76)

1. An apparatus for analyte concentration display, comprising:

a near-infrared noninvasive glucose concentration analyzer;

a display module integrated into said analyzer; and

means for video graphic display of historical analyte concentrations in a time compressed format on said display module.

2. The apparatus of claim 1 , wherein said historical analyte concentrations represent at least five glucose concentrations.

3. The apparatus of claim 2 , said historical analyte concentrations further comprising a time period, wherein said video graphic display represents glucose concentrations within said time period.

4. The apparatus of claim 3 , wherein said time period comprises a period of any of about:

a period of a glucose excursion;

a day;

a week;

a month; and

several months.

5. The apparatus of claim 4 , wherein said video graphic display comprises any of:

a slider graph;

a treadmill graph; and

a tachometer graph.

6. The apparatus of claim 5 , wherein said video graphic display comprises a first animated graphical representation of at least one of said historical glucose concentrations.

7. The apparatus of claim 6 , wherein said first animated graphical representation represents any of:

a current time stamped glucose concentration; and

an individual glucose concentration, wherein said individual glucose concentration comprises one of said historical analyte concentrations.

8. The apparatus of claim 7 , wherein said video graphic display comprises a second animated graphical representation of any of:

a maximum achieved glucose concentration;

a minimum achieved glucose concentration;

a targeted glucose concentration;

a targeted maximum glucose concentration; and

a targeted minimum glucose concentration.

9. The apparatus of claim 3 , further comprising a user interface.

10. The apparatus of claim 9 , wherein said time period is controlled through said user interface.

11. The apparatus of claim 1 , wherein said display module comprises a color display screen.

12. The apparatus of claim 11 , said historical analyte concentrations further comprising at least three physiological glucose concentration ranges, wherein said video graphic display represents said historical glucose concentrations for each of said ranges in different colors.

13. The apparatus of claim 12 , wherein said physiological glucose concentration ranges comprise at least two of:

a range of hyperglycemic glucose concentrations;

a range of normal glucose concentrations;

a range of hypoglycemic glucose concentrations; and

a targeted glucose concentration range.

14. The apparatus of claim 11 , wherein said display module comprises an input touch screen.

15. The apparatus of claim 1 , wherein said analyzer comprises:

a base module in a first container;

a communication bundle having a first end and a second end, wherein said first end connects to said base module; and

a sample module in a second container separated from said first container, wherein said second end of said communication bundle connects to said sample module.

16. An apparatus for representation of data associated with historical noninvasive glucose concentrations, comprising:

a near-infrared based noninvasive glucose analyzer;

means for conveying underlying information of tabulated data via a user interface module, wherein said means for conveying comprises:

means for reducing said tabulated data via clustering into groups;

means for generating a correlation between at least one of said group to a user performing action; and

means for presenting graphically to the user said correlation,

wherein presentation of said correlation of said action to said group provides said underlying information to the user or a medical professional allowing action specific diagnosis or treatment.

17. The apparatus of claim 16 , wherein said analyzer comprises of:

a sample module in a first housing;

a base module in a second housing; and

means for communication between said sample module and said base module.

18. The apparatus of claim 16 , wherein a group of said groups comprises:

a set of said glucose concentrations defined by class.

19. The apparatus of claim 16 , wherein said step of reducing said tabulated data via clustering into groups result in any of:

a group of points representing said glucose concentrations represented on two or more axes; and

a group of points relative to a threshold.

20. The apparatus of claim 19 , wherein said axes comprise any of linear, nonlinear, average, maximum, and area representations.

21. The apparatus of claim 16 ,further comprising means for selection of a cluster via the user interface module.

22. The apparatus of claim 21 , wherein said user interface module comprises any of:

a touch screen;

a stylus;

a keyboard; and

a button driven interface,

whereby selection of at least one of said historical glucose concentrations is performed.

23. The apparatus of claim 22 , wherein said means for selection of a cluster comprises any of:

a look-up table; and

a historical table.

24. The apparatus of claim 23 , wherein said means for selection of a cluster further comprises any of:

a central processing unit; and

a programmable logic device.

25. The apparatus of claim 16 , wherein said the means for presenting graphically comprises publication on the user interface module of any of:

a pie graph;

a histogram;

a time of day analysis;

a glucose treatment grid; and

a tabulation of said values of variables associated with points in said cluster.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2012
From: SENSYS MEDICAL, LIMITED
To: GLT ACQUISITION CORP.
Reel/Frame 028912/0036 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2012
From: SENSYS MEDICAL, INC.
To: SENSYS MEDICAL, LTD
Reel/Frame 028714/0623 →
LIEN RELEASE Recorded Apr 14, 2009
From: GLENN PATENT GROUP
To: SENSYS MEDICAL, INC.
Reel/Frame 022542/0360 →
LIEN Recorded Jan 20, 2009
From: SENSYS MEDICAL, INC.
To: GLENN PATENT GROUP
Reel/Frame 022117/0887 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2005
From: HOCKERSMITH, LINDA J; HAZEN, KEVIN H; RUCHTI, TIMOTHY L
To: SENSYS MEDICAL, INC.
Reel/Frame 016083/0464 →